Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015.

GBD 2015 HIV Collaborators. · 2016

Read Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. by GBD 2015 HIV Collaborators. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5056319.txt.

Introduction

The Global Burden of Disease 2015 HIV collaborators estimate the world HIV epidemic in The Lancet HIV in 2016. Their report gives new infections, people living with HIV, treatment coverage, and deaths for 195 countries and territories from 1980 to 2015. It was built with the United Nations' own projection tools, updated with fresh reviews and demographic data.

World incidence peaked in 1997 at 3.3 million new infections. After a fast fall to 2005, new infections have held near 2.6 million a year, while deaths have dropped since the mid-2000s as treatment spread. Because people on treatment live longer, the number living with HIV kept climbing, reaching 38.8 million in 2015. HIV rose over the period from the thirty-ninth to the eleventh ranked cause of death worldwide. The authors stress that country patterns differ sharply, so global averages hide local epidemics that still need targeted programs.

Catalog record

CREATORGBD 2015 HIV Collaborators.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE110 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5056319

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 Published in: The Lancet. HIV DOI: 10.1016/S2352-3018(16)30087-X ABSTRACT Summary Background Timely assessment of the burden of HIV/AIDS is essential for policy setting and programme evaluation. In this report from the Global Burden of Disease Study 2015 (GBD 2015), we provide national estimates of levels and trends of HIV/AIDS incidence, prevalence, coverage of antiretroviral therapy (ART), and mortality for 195 countries and territories from 1980 to 2015. Methods For countries without high-quality vital registration data, we estimated prevalence and incidence with data from antenatal care clinics and population-based seroprevalence surveys, and with assumptions by age and sex on initial CD4 distribution at infection, CD4 progression rates (probability of progression from higher to lower CD4 cell-count category), on and off antiretroviral therapy (ART) mortality, and mortality from all other causes. Our estimation strategy links the GBD 2015 assessment of all-cause mortality and estimation of incidence and prevalence so that for each draw from the uncertainty distribution all assumptions used in each step are internally consistent. We estimated incidence, prevalence, and death with GBD versions of the Estimation and Projection Package (EPP) and Spectrum software originally developed by the Joint United Nations Programme on HIV/AIDS (UNAIDS). We used an open-source version of EPP and recoded Spectrum for speed, and used updated assumptions from systematic reviews of the literature and GBD demographic data. For countries with high-quality vital registration data, we developed the cohort incidence bias adjustment model to estimate HIV incidence and prevalence largely from the number of deaths caused by HIV recorded in cause-of-death statistics. We corrected these statistics for garbage coding and HIV misclassification. Findings Global HIV incidence reached its peak in 1997, at 3·3 million new infections (95% uncertainty interval [UI] 3·1–3·4 million). Annual incidence has stayed relatively constant at about 2·6 million per year (range 2·5–2·8 million) since 2005, after a period of fast decline between 1997 and 2005. The number of people living with HIV/AIDS has been steadily increasing and reached 38·8 million (95% UI 37·6–40·4 million) in 2015. At the same time, HIV/AIDS mortality has been declining at a steady pace, from a peak of 1·8 million deaths (95% UI 1·7–1·9 million) in 2005, to 1·2 million deaths (1·1–1·3 million) in 2015. We recorded substantial heterogeneity in the levels and trends of HIV/AIDS across countries. Although many countries have experienced decreases in HIV/AIDS mortality and in annual new infections, other countries have had slowdowns or increases in rates of change in annual new infections. Interpretation Scale-up of ART and prevention of mother-to-child transmission has been one of the great successes of global health in the past two decades. However, in the past decade, progress in reducing new infections has been slow, development assistance for health devoted to HIV has stagnated, and resources for health in low-income countries have grown slowly. Achievement of the new ambitious goals for HIV enshrined in Sustainable Development Goal 3 and the 90-90-90 UNAIDS targets will be challenging, and will need continued efforts from governments and international agencies in the next 15 years to end AIDS by 2030. Funding Bill & Melinda Gates Foundation, and National Institute of Mental Health and National Institute on Aging, National Institutes of Health. INTRODUCTION HIV/AIDS is a leading cause of death and disease burden, especially in sub-Saharan Africa.1, 2, 3, 4, 5 Introduction of antiretroviral therapy (ART) in 1996 greatly reduced HIV-related mortality.6, 7 Creation of the Joint United Nations Programme on HIV/AIDS (UNAIDS) in 1996; the Global Fund to Fight AIDS, Tuberculosis and Malaria in 2002; and the US President's Emergency Plan for AIDS Relief (PEPFAR) in 2003, galvanised the mobilisation of resources to combat the HIV epidemic. In the past 15 years, the global community has provided US$109·8 billion of development assistance to curb the HIV/AIDS epidemic.8 As a result, HIV mortality has declined overall in low-income and middle-income countries since 2004.1 The success of ART and prevention of mother-to-child transmission programmes led to ambitious calls to eliminate HIV as a public health threat. However, maintenance and scale-up of sufficiently funded AIDS efforts will be crucial to realise the goal of ending the AIDS epidemic as a public health threat by 2030.9 Achievement of these goals, including the UNAIDS 90-90-90 targets, which aim to have 90% of people living with HIV know their status, 90% of those detected treated with ART, and 90% of those receiving treatment achieving viral load suppression,10 requires a coordinated global scale-up of prevention programmes, pre-exposure prophylaxis (PrEP), and detection and treatment programmes.11 However, development assistance for health targeted for HIV has stagnated since 2010, and, in many low-income countries, national resources for health are scarce and expected to grow slowly.12, 13 Research in contextEvidence before this studyWe searched PubMed between Aug 18, 2015, and April 3, 2016, for studies that comprehensively assessed the burden of HIV/AIDS globally. Our search terms included “HIV” and “global” and “mortality” or “incidence” or “prevalence”, and searches were restricted to articles published in English up to April 1, 2016. To our knowledge through the search, Global Burden of Disease (GBD) and UNAIDS are the only two sources that provide comparable evaluations of levels and trends of the HIV/AIDS epidemic at both the global and country level. UNAIDS has provided global estimates on HIV/AIDS since 1997, and has developed two epidemiological programs to estimate incidence, prevalence, and mortality: Estimation and Projection Package (EPP) and Spectrum. GBD 2013 used improved versions of Spectrum to generate comprehensive, comparable estimates of levels and trends of HIV/AIDS incidence, prevalence, and mortality across geographies. Studies from both organisations have shown rapid changes in the HIV/AIDS epidemic worldwide and that up-to-date epidemiological and demographic information is needed to more accurately assess the burden of HIV at both the country and global level.Added value of this studyFor GBD 2015, we systematically updated the key inputs to our HIV/AIDS estimation process, which includes prevalence from national surveys and antenatal care clinics, demographic input on fertility and migration, mortality on and off antiretroviral therapy (ART), and background HIV-free mortality; updates to these inputs were concluded in April, 2016; October, 2015; December, 2015; and April, 2016, respectively. We also improved the integration of EPP, Spectrum, and the GBD all-cause mortality estimation process to make them internally consistent. For countries with high-quality vital registration data, we developed a new method to improve the accuracy of and consistency among estimates of HIV/AIDS incidence, prevalence, and mortality leveraging the number of deaths recorded each year as caused by HIV/AIDS. This method also allowed us to use vital registration data to generate plausible incidence curves in countries that are not part of UNAIDS' results, and in subnational units where we previously only had national-level data. We developed an ensemble model to reconcile HIV mortality estimates from EPP and Spectrum and from those indicated in GBD's all-cause mortality estimation process. Remarkable progress has been made in curbing the HIV/AIDS epidemic worldwide; however, our findings emphasise the need for continued efforts from governments and international agencies in the next 15 years to end AIDS by 2030, in view of the low ART coverage and stagnation in decline of annual new infections in

Read the complete text